MDTi's latest addition to their product portfolio 'First-Step', a mobile leg bath was featured today in the Daily Mail. You can read the review online on the Daily Mail's website.

MDTi's Anti-DVT product, Physio-Master was featured today in the Daily Mail. You can read the review online on the Daily Mail's website (please note that the price for teh Physio-Master was misprinted, the correct price is £26.04).

MDTi's innovative Hoo-kOn Portable IV stand is helping Newark teenager Karl Hassell to lead a fuller more adventuresome life. Read all about it in the article recently published in 'Link', the magazine for the Association for Spina Bifida Hydrocephalus. For further information about the ASBAH visit their website.

Medical Devices Technology International Ltd (MDTi) has beat off stiff competition to be highly commended in the Best Innovative Product and Best Knowledge Transfer categories of the prestigious ICT Excellence Awards 2009.

The growing and successful Wolverhampton based company is supported by MidTECH the West Midlands NHS Innovation Hub and was recognised for its home E-Health LUTS self monitoring system.

Wolverhampton-based Medical Devices Technology International Ltd (MDTi) will be working with Numark, the UK's largest virtual chain of independent pharmacists as from October 2009. The aim is to give millions of healthcare sufferers access to innovative healthcare products invented by frontline professionals and patients from within the NHS.

From the inception of MDTi, the company's mantra has been to ensure that access to improved healthcare products at affordable prices was a right and not a pledge to the consumer health marketplace. “We are over the moon to be working with the national chain of retail pharmacies, Numark, who have shown how much they are in-tune with our philosophy and those of the UK consumers,” said Martin Levermore CEO of MDTi.

Martin Levermore, Chief Executive Officer of MDTi, said: "When I and my fellow directors came up with the idea of the company, we had a very strong ethical drive, whilst not losing the important balance with being commercial, and was fed up with having to look abroad for products which we knew started their lives as ideas by U.K. based clinicians. We were acutely aware that no other company in the country were working with the NHS to capture the ideas coming from their people under a single brand and hence these innovations were taking a lifetime to come to market to help patients.